Pulmonary pleomorphic carcinoma treated with PD‐1 inhibitor: Two case reports
Abstract Pulmonary polymorphic carcinoma (PPC) is a rare and poorly differentiated form of non‐small cell lung cancer (NSCLC), accounting for just approximately 0.1% to 0.4% of all NSCLC cases. Historically, the conventional treatments for PPC have been linked to a grim prognosis. However, with the...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Wiley
2023-11-01
|
| Schriftenreihe: | Thoracic Cancer |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1111/1759-7714.15120 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|